Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · IEX Real-Time Price · USD
47.54
+2.88 (6.45%)
At close: May 1, 2024, 4:00 PM
48.00
+0.46 (0.97%)
After-hours: May 1, 2024, 6:33 PM EDT

Soleno Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
33
Market Cap
1.59B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 2015607.47K--
Dec 31, 20140--
Dec 31, 20133.00M--
Dec 31, 20120--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Addus HomeCare 1.06B
U.S. Physical Therapy 604.80M
Veracyte 361.05M
ADMA Biologics 258.22M
Dynavax Technologies 232.28M
LeMaitre Vascular 193.48M
Ardelyx 124.46M
Protagonist Therapeutics 60.00M
Revenue Rankings